Evaluation of Real-World Data on the Performance of the TECNIS Odyssey™ IOL
NCT ID: NCT05991960
Last Updated: 2024-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
96 participants
OBSERVATIONAL
2023-09-11
2023-12-04
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
User Acceptability Evaluation of Pseudophakic Patients Previously Implanted With the TECNIS Odyssey IOL
NCT06005675
Odyssey Evaluation in Post LASIK Patients
NCT07260695
Clinical Outcomes With Bilateral Implantation of Odyssey IOLs
NCT06550375
RLE Outcomes With Bilateral Implantation of Odyssey IOLs
NCT06979557
Visual Outcomes of Tecnis Symfony Opti-Blue EDOF Intraocular Lens (IOL)
NCT06500416
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention
No study treatments will be administered during this retrospective study. However, data will be collected from medical records of patients who have been treated with the subject device of this study.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Enrollment at least 21 days after second eye surgery;
3. Clear intraocular media in each eye.
4. Signed consent and data protection documentation necessary to comply with applicable privacy laws pertaining to medical treatment in the governing countries.
Exclusion Criteria
2. Use of systemic or ocular medication that may affect vision;
3. Prior corneal refractive surgery in each eye (i.e., LASIK, PRK, SMILE, RK, CK); NOTE: Limbal relaxing incisions (LRI) are permissible as planned at the time of surgery (intraoperatively) but not postoperatively within the retrospective analysis window;
4. Ongoing adverse events in each eye that might impact outcomes during the study visit as determined by the investigator;
5. Acute or chronic disease or condition, ocular trauma or surgery that may affect vision in each eye (e.g., clinically significant macular degeneration, glaucoma, cystoid macular edema, proliferative diabetic retinopathy, keratoconus etc.).
6. Amblyopia, strabismus, nystagmus in each eye.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johnson & Johnson Surgical Vision, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johnson & Johnson Surgical Vision, Inc. Clinical Trial
Role: STUDY_DIRECTOR
Johnson & Johnson Surgical Vision, Inc.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Assil Eye Institute
Beverly Hills, California, United States
The Eye Institute of West Florida
Largo, Florida, United States
Center for Sight
Sarasota, Florida, United States
Aloha Vision Consultants
Honolulu, Hawaii, United States
OCLI Vision
Garden City, New York, United States
Vance Thompson Vision
West Fargo, North Dakota, United States
Cleveland Eye Clinic
Brecksville, Ohio, United States
Carolina EyeCare Physicians
Mt. Pleasant, South Carolina, United States
Loden Vision Centers
Goodlettsville, Tennessee, United States
Dell Laser Consultants
Austin, Texas, United States
Whitsett Vision Group
Houston, Texas, United States
Virginia Eye Consultants
Norfolk, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DIOL112MRWD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.